Y-mAbs Therapeutics, Inc.
YMAB
$4.73
-$0.18-3.67%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/13/2025
-
MarketBeat
3/13/2025
-
MarketBeat
3/12/2025
-
Tickeron - Stocks
3/12/2025
-
Ticker Report
3/12/2025
-
MarketBeat
3/12/2025
-
Ticker Report
3/8/2025
-
MarketBeat
3/8/2025
-
Ticker Report
3/7/2025
-
Tickeron - Technical Analysis
3/7/2025
-
Tickeron - Stocks
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Just Reported And Analysts Have Been Cutting Their Estimates
3/7/2025
-
Simply Wall St
3/6/2025
-
MarketBeat
3/6/2025
-
MarketBeat
3/6/2025
-
MarketBeat
3/6/2025
-
Ticker Report
3/5/2025
-
Benzinga
3/5/2025
-
Ticker Report
3/5/2025
-
TipRanks Financial Blog
3/5/2025
-
The Fly
3/5/2025
-
The Fly
3/5/2025
-
The Fly
3/5/2025
-
The Fly
3/5/2025
-
Simply Wall St
3/5/2025
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 4, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
646 885 8505
Address
230 Park Avenue
New York, NY 10169
New York, NY 10169
Country
Year Founded
Business Description
Sector
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer in the...
more
